Tag: sales
AstraZeneca’s Brilinta won its coveted stroke-prevention nod. Will it be enough...
A few months ago, AstraZeneca’s Brilinta added a new U.S. indication to reduce the chance of a first heart attack or stroke in certain...
GW plots path to new drug approvals as Epidiolex tops sales...
GW Pharmaceuticals is looking to blaze new trails in cannabinoid prescription meds, this time in multiple sclerosis. The company has launched a phase 3 trial of...
Takeda offers Japanese sales, admin staffers early retirement in post-Shire slimdown
The ax has fallen on Takeda’s home business in Japan as part of a companywide restructuring triggered by its $59 billion Shire acquisition.
Takeda is...
Samsung Biologics plots $2B ‘super plant’ as COVID-19 sends sales through...
The COVID-19 pandemic has caused shockwaves across the pharmaceutical industry with some drugmakers booking major losses in recent months. But the crisis hasn't been a...
Immunology launches buoy AbbVie sales as COVID-19 swamps ex-Allergan aesthetics biz
Only months into its massive merger with Allergan, AbbVie has been forced to contend with a pandemic challenge to its brand-new aesthetics business. But...
ASCO: AstraZeneca’s Tagrisso, headed for big sales boost, cuts lung cancer...
In mid-April, at the recommendation of an independent data monitoring committee, AstraZeneca unblinded a phase 3 trial of Tagrisso two years early. Now, the...
